Byproduct of cholesterol interferes with the beneficial ramifications of estrogen on the heart A new research possibly offers a biological reason why hormone replacement therapy fails to protect some postmenopausal women from cardiovascular disease. The culprit appears to be a molecule called 27-hydroxycholesterol, or 27HC, a byproduct created as your body processes cholesterol . The study that was carried out by experts at the University of Texas Southwestern INFIRMARY in Dallas has found that a byproduct of the cholesterol rate of metabolism interferes with the beneficial effects estrogen is wearing the cardiovascular system; the revelation could provide a better knowledge of the interplay between estrogen and cholesterol in heart disease.

However, numerous studies have revealed the presence of many chlorination by-items in the water. Recent research suggests that prenatal contact with these by-products might increase the threat of birth defects. Related StoriesCharles Bonnet syndrome: an interview with Dr. Dominic ffytcheLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. The experts used statistical analyses to discover if drinking tap water containing high, moderate or low degrees of chlorination by-products increased the risk of 11 common birth defects. Although the researchers found no direct link between the prevalence of any birth defect and the known degree of exposure, their calculations exposed that exposure to high levels of by-products substantially increased the chance of three common defects: ventricular septal defects , cleft palate, and anencephalus .